News
-
New APC Pres and VP
Wednesday | Feb 21 2018THE Australian Pharmacy Council (APC) has elected Associate Professor Sue Kirsa as President commencing 26 Feb, and Professor Iqbal Ramzan as Vice President, both for a two-year term.
-
Deprescribing data
Wednesday | Feb 21 2018THE National Health and Medical Research Council (NHMRC) has approved the recommendations made in the 'Evidence-based clinical practice guideline for deprescribing cholinesterase inhibitors and memantine' developed by the University of Sydney in partnership with the NHMRC Cognitive Decline Partnership Centre and the Bruyre Research Institute in Canada.
-
Managing GORD
Wednesday | Feb 21 2018GUILD Learning and Development is partnering with RB in the development of a QCPP Refresher Training online course titled 'The burning issue: Managing breakthrough symptoms of gastro-oesophageal reflux'.
-
Hunt urges PBAC
Wednesday | Feb 21 2018RESPONDING to interest from pharmaceutical companies and cancer patient advocacy groups, the Minister for Health Greg Hunt has requested that the Pharmaceutical Benefits Advisory Committee (PBAC) consider options for listing of pan-tumour indications for PDL1 cancer immunotherapies on the Pharmaceutical Benefits Scheme (PBS).
-
AFP Adelaide ice bust
Wednesday | Feb 21 2018MINISTER for Rural Health Bridget McKenzie has congratulated the Australian Federal Police, for their role in a major methamphetamine (ice) bust in Adelaide, South Australia.
-
Organ donation >10K
Wednesday | Feb 21 2018FEDERAL Minister for Aged Care and Indigenous Health Ken Wyatt has announced that the national organ donation program has saved more than 10,000 lives in 2017, and improved the lives of 1,675 Australians with a further 9,600 benefiting from eye and tissue transplants.
-
CW nets major partnership
Wednesday | Feb 21 2018AUSTRALIAN pharmacy discount retail group Chemist Warehouse has again linked with Beach Netball ("It's netball, but not as you know it") as a major partner and is gearing up to support the upcoming 2018 series across the country.
-
EBOS H1 earnings up 15.6%
Wednesday | Feb 21 2018ASX-LISTED marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products EBOS, has announced a record interim unaudited net profit of $76.7m for the six months to 31 Dec 2017, with EBITDA up 15.6% and net profit after tax up 11.5%.
-
Gabapentinoid abuse up
Wednesday | Feb 21 2018THE US Food and Drug Administration (FDA) is actively looking into the potential misuse and abuse of gabapentinoids, a class of drugs that includes Pfizer's Neurontin (gabapentin) and Lyrica (pregabalin), which have been approved to treat a number of conditions such as postherpetic neuralgia, fibromyalgia and neuropathic pain.
-
